On 2021 May 15, Synceres Biotechnology (Shenzhen) Co., Ltd. and Angel yeast Co., Ltd. officially announced the joint foundation of Hubei angel senris Biotechnology Co., Ltd. The CEO of Synceres, Xibin Zhou ,and Xiong Tao, CEO of Angel, signed a joint venture agreement. This marks the all-round strategic cooperation between Synceres and Angel, and the commencement for commercialization of Synceres’ synthetic biology projects.
Synthetic biology aims to take use of the basic rules of biosynthesis to design and construct new biological systems with specific physiological functions, thus establishing bio manufacturing approaches for drugs, functional materials and alternative energy sources. Synthetic biology is one of the most promising fields of modern science. It holds the key for commercializing biological research advances. It ranks as the top ten technologies that may change the future world. It has great potential to fuel economic growth while maintaining a low-carbon economy, as well as to create employment opportunities .
Synceres is a high-tech company engaged in the development of new technologies and new products. It focuses on industrialization of synthetic biology research results, creation of the intelligent equipment system for the R&D purposes, rationally designed life science and precision manufacturing. At present, Synceres has completed the laboratory-scale industrialization test of cannabinoids and new liquid rubber material (HVR), leading the way in the industrialization of corresponding products in the world. Synceres has also applied for several related invention patents. In December 2020, Synceres was listed as one of “the 50 most noteworthy synthetic biology companies in the world” in CB insights .
Angel yeast Co., Ltd. is a professional company engaged in the production, operation and technical service of yeast and yeast derivatives products, and is a national high-tech enterprise. The company’s leading products include live yeast cells, yeast extract, yeast nutritional supplements, food additives, etc. Angel’s marker share covers baking, fermented pasta, wine making and other food manufacturing industries,health care, as well as animal breeding. Angel, is the largest yeast company in Asia and the third largest in the world, and holds huge advantage in the fermentation industry. Its ability in industrialization and applied R&D will rapidly promote the transformation of new technologies and industries.
On the one hand, the cooperation between Synceres and Angel is a breakthrough for the synthetic biology companies, solving the “three difficult problems”, referred to as industrialization, mass production and marketing, for commercialization of the synthetic biology advances. On the other hand, Angel as a leading traditional yeast fermentation giant started matching into the fast-growing synthetic biology field, paving its way for future sustainable development.
The foundation of Hubei Angel Synceres Biotechnology Co., Ltd. creates a win-win situation, as it complemented the shortcomings of both companies. It can not only speed up the commercialization process of Synceres projects, but also explore a new path for the commercialization of synthetic biotechnology, which will have a far-reaching impact on the innovation and development of the whole synthetic biotechnology industry.